Vera Therapeutics snags $80m Series C

Vera Therapeutics, a developer of treatments for immunological and inflammatory diseases, has secured $80 million in Series C financing.

Vera Therapeutics, a developer of treatments for immunological and inflammatory diseases, has secured $80 million in Series C financing. Abingworth LLP led the round.

Source: Press Release